Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayalew Tefferi

Showing results (1-10 of 910) with videos related to

Pageof 91
Sort By:
American Journal of Hematology|July 20, 2023
Jaktinib and momelotinib for the treatment of myelofibrosis-Birds of a feather?Ayalew Tefferi
Mayo Clinic Proceedings|September 24, 2010
Myelodysplastic syndromes--many new drugs, little therapeutic progressAyalew Tefferi
American Journal of Hematology|November 17, 2011
Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and managementAyalew Tefferi
Mayo Clinic Proceedings|February 14, 2006
Iron chelation therapy for myelodysplastic syndrome: if and whenAyalew Tefferi
Current Opinion in Hematology|February 4, 2006
New insights into the pathogenesis and drug treatment of myelofibrosisAyalew Tefferi
American Journal of Hematology|January 7, 2010
Leukocytosis as a risk factor for thrombosis in myeloproliferative neoplasms-biologically plausible but clinically uncertainAyalew Tefferi
Leukemia & Lymphoma|February 26, 2008
JAK and MPL mutations in myeloid malignanciesAyalew Tefferi
Cancer Treatment and Research|February 21, 2008
Primary myelofibrosisAyalew Tefferi
Blood|August 13, 2016
Somatic JAK2 mutations and their tumor phenotypesAyalew Tefferi
Seminars in Hematology|April 12, 2003
Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the newAyalew Tefferi
Pageof 91

Showing results (1-10 of 910) with videos related to

Sort By:
Pageof 91
American Journal of Hematology|July 20, 2023
Jaktinib and momelotinib for the treatment of myelofibrosis-Birds of a feather?Ayalew Tefferi
Mayo Clinic Proceedings|September 24, 2010
Myelodysplastic syndromes--many new drugs, little therapeutic progressAyalew Tefferi
American Journal of Hematology|November 17, 2011
Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and managementAyalew Tefferi
Mayo Clinic Proceedings|February 14, 2006
Iron chelation therapy for myelodysplastic syndrome: if and whenAyalew Tefferi
Current Opinion in Hematology|February 4, 2006
New insights into the pathogenesis and drug treatment of myelofibrosisAyalew Tefferi
American Journal of Hematology|January 7, 2010
Leukocytosis as a risk factor for thrombosis in myeloproliferative neoplasms-biologically plausible but clinically uncertainAyalew Tefferi
Leukemia & Lymphoma|February 26, 2008
JAK and MPL mutations in myeloid malignanciesAyalew Tefferi
Cancer Treatment and Research|February 21, 2008
Primary myelofibrosisAyalew Tefferi
Blood|August 13, 2016
Somatic JAK2 mutations and their tumor phenotypesAyalew Tefferi
Seminars in Hematology|April 12, 2003
Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the newAyalew Tefferi
Pageof 91